Skip to main content

Len Blavatnik Reports a $15 Million DAWN Buy

October 23, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Len Blavatnik.

Blavatnik reported a purchase of $14.9 million in Day One Biopharmaceuticals $DAWN.

Here’s The Hot Corner, with data through October 20, 2023:

Point72 Asset Management filed a 13G for Semtech Corporation $SMTC revealing an initial stake of 7.30%.

In another Form 4, Ares Management revealed a purchase of 150,000 shares in Frontier Communications Parent $FYBR.

Stay tuned. We'll be back on Tuesday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team